Yu Hu

Also affiliated with University of Electronic Science and Technology of China, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Medical University Cancer Institute and Hospital, Mianyang Central Hospital, Second Hospital of Shandong University, Chinese Academy of Medical Sciences Dermatology Hospital, Fuling Center Hospital of Chongqing, Wuhan Union Hospital, Institute of Hematology & Blood Diseases Hospital, Wuhan Engineering Science & Technology Institute, Hubei Cancer Hospital, Qilu Hospital of Shandong University, Huazhong University of Science and Technology, CAE (Canada)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Have we been qualifying measurable residual disease correctly?”.

Have we been qualifying measurable residual disease correctly?

Leukemia(2023)10.1038/s41375-023-02026-4

N/A

0.312DataRank · unranked

7 citations

Saibing Qi, Xueou Liu, Li Zhang, Yu Hu, Qiujin Shen +11 more

Factors Predicting Progression to Severe COVID-19: A Competing Risk Survival Analysis of 1753 Patients in Community Isolation in Wuhan, China

Engineering(2021)10.1016/j.eng.2021.07.021

N/A

0DataRank · unranked

12 citations

Hui Sun, Mei Heng, Xunliang Tong, Pascal Geldsetzer, Zhuoran Wang +6 more